UBS (Lux) Fund Solutions SICAV - UBS Solactive China Technology UCITS ETF hEUR acc- Capitalisation
No trades
Key stats
About UBS (Lux) Fund Solutions SICAV - UBS Solactive China Technology UCITS ETF hEUR acc- Capitalisation
Home page
Inception date
Mar 5, 2021
Structure
Luxembourg SICAV
Replication method
Physical
Dividend treatment
Capitalizes
Primary advisor
UBS Asset Management (Europe) SA
ISIN
LU2265794946
The UBS Solactive China Technology UCITS ETF sub-fund is passively managed and will take proportionate exposure on the components of the Solactive China Technology (Net Return)
Classification
Returns
1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
---|---|---|---|---|---|---|
Price performance | — | — | — | — | — | — |
NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Technology Services
Electronic Technology
Health Technology
Retail Trade
Producer Manufacturing
Stocks99.98%
Technology Services37.95%
Electronic Technology15.94%
Health Technology14.65%
Retail Trade12.42%
Producer Manufacturing11.22%
Consumer Durables6.66%
Communications1.13%
Health Services0.01%
Bonds, Cash & Other0.02%
Cash0.02%
Stock breakdown by region
Asia100.00%
North America0.00%
Latin America0.00%
Europe0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
CITE invests in stocks. The fund's major sectors are Technology Services, with 37.95% stocks, and Electronic Technology, with 15.94% of the basket. The assets are mostly located in the Asia region.
CITE top holdings are Alibaba Group Holding Limited and Tencent Holdings Ltd, occupying 12.42% and 10.37% of the portfolio correspondingly.
CITE assets under management is 69.63 M EUR. It's risen 65.25% over the last month.
CITE fund flows account for 51.09 M EUR (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, CITE doesn't pay dividends to its holders.
CITE shares are issued by UBS Group AG under the brand UBS. The ETF was launched on Mar 5, 2021, and its management style is Passive.
CITE expense ratio is 0.50% meaning you'd have to pay 0.50% of your investment to help manage the fund.
CITE follows the Solactive China Technology Index. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
CITE invests in stocks.
CITE price has risen by 11.33% over the last month, and its yearly performance shows a 85.37% increase. See more dynamics on CITE price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 12.22% over the last month, showed a 23.84% increase in three-month performance and has increased by 93.55% in a year.
NAV returns, another gauge of an ETF dynamics, have risen by 12.22% over the last month, showed a 23.84% increase in three-month performance and has increased by 93.55% in a year.
CITE trades at a premium (0.79%) meaning the ETF is trading at a higher price than the calculated NAV.